Vycor Medical, Inc. President David Cantor to Be Interviewed Today on Clear Channel Business Talk Radio DFW1190AM
23 January 2014 - 11:15PM
Marketwired
Vycor Medical, Inc. President David Cantor to Be Interviewed Today
on Clear Channel Business Talk Radio DFW1190AM
Mr. Cantor to Be Interviewed Live Today at 2:00 pm CST / 3:00 pm
EST on The Traders Network Radio Show by Host Michael Yorba
BOCA RATON, FL--(Marketwired - Jan 23, 2014) - Vycor Medical,
Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite
of FDA cleared products, announced today that President David
Cantor will interviewed live by host Michael Yorba on Clear Channel
Business Talk Radio's The Traders Network.
The interview will air today Thursday, January 23, 2014, at
2:00pm U.S. Central Standard Time / 12:00pm Pacific Standard Time /
3:00pm Eastern Standard Time at DFW1190AM and broadcasted
nationally via iHeart Radio.
We encourage all investors, institutional analysts, industry
professionals, customers and others who are interested in learning
more about Vycor Medical's NovaVision recent developments to tune
in and listen live via Clear Channel's iHeart Radio stream. Details
below.
Live Interview via iHeart Radio Stream:
http://www.iheart.com/live/4276/?autoplay=true Date: January 23,
2014 Time: 2:00pm CST | 12:00pm PST | 3:00pm EST (U.S.) Network:
Clear Channel Station: DFW 1190AM Host: Michael Yorba
About Clear Channel: Clear Channel Media and Entertainment's
more than 840 radio stations offer programming nationwide.
Individual station brands connect with diverse audiences in local
markets across the country. DFW1190AM.com Dallas-Ft. Worth.
www.clearchannel.com.
About Michael Yorba: Michael Yorba is the featured host of Clear
Channels DFW 1190AM in Dallas-Ft. Worth, TX. For the past six years
he has been integrally involved with the media industry in various
capacities including building an IPTV Network, developing,
producing and hosting a daily one hour talk show called Commodity
Classics, and then later The Traders Network, defined as an
audience empowered interactive financial program that has been
broadcast live on Internet, television and radio. His focus has
been on derivative portfolio analysis for individual and corporate
clients through the use of futures and futures options, managed
funds, and Forex. www.yorbamedia.com.
About Vycor Medical, Inc.
Vycor Medical, Inc. ("Vycor") is dedicated to providing the
medical community with innovative and superior surgical and
therapeutic solutions and has a growing portfolio of FDA-cleared
medical solutions that are changing and improving lives every day.
The Company operates two wholly-owned business units: Vycor Medical
and NovaVision, both of which adopt a minimally or non-invasive
approach. Both technologies have exceptional sales growth
potential, address large potential markets, have the requisite
regulatory approvals and are commercialized and generating
revenue.
Vycor Medical's flagship, ViewSite™ Surgical Access Systems
(VBAS) is a suite of clear cylindrical minimally invasive
disposable devices that hold the potential for speedier, safer and
more economical brain surgeries and a quicker patient discharge.
VBAS is designed to optimize neurosurgical site access, reduce
patient risk, accelerate recovery and add tangible value to the
professional medical community. Vycor Medical is ISO 13485:2003
compliant, has FDA 510(K) clearance for VBAS for brain and spine
surgeries and regulatory approvals for brain surgeries in
Australia, Canada, China, Europe, Japan, Korea and Russia. For an
overview of Vycor Medical's VBAS see
http://player.vimeo.com/video/39766887
NovaVision develops and provides science-driven neurostimulation
therapy and other medical technologies that help improve and
partially restore sight in patients with neurological vision
impairments. The company's proprietary Visual Restoration Therapy®
(VRT) platform is clinically supported to improve lost vision
resulting from stroke, traumatic brain injury ("TBI"), or other
acquired brain injuries. VRT is the only FDA 510K cleared medical
device in the U.S. aimed at the restoration of vision for
neurologically induced vision loss and can be prescribed by any
ophthalmologist, optometrist, neurologist or physiatrist. VRT also
has CE Marking for the EU. NovaVision also recently launched
NeuroEyeCoach™, a new Internet-based "direct to the patient"
saccadic eye training program. The Company also provides Neuro-Eye
Therapy (NeET) in the EU, aimed at increasing visual sensitivity
deep within the field defect. For an overview of NovaVision see:
http://player.vimeo.com/video/39765566
For the latest information on the company, including media and
other coverage, and to learn more, please go online at
www.vycormedical.com or www.novavision.com
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words "forecast",
"anticipate", "estimate", "project", "intend", "expect", "should",
"believe", and similar expressions are intended to identify
forward-looking statements. These forward-looking statements
involve, and are subject to known and unknown risks, uncertainties
and other factors which could cause Vycor Medical's actual results,
performance (financial or operating) or achievements to differ from
the future results, performance (financial or operating) or
achievements expressed or implied by such forward-looking
statements. The risks, uncertainties and other factors are more
fully discussed in Vycor Medical's filings with the U.S. Securities
and Exchange Commission. All forward-looking statements
attributable to Vycor Medical herein are expressly qualified in
their entirety by the above-mentioned cautionary statement. Vycor
Medical disclaims any obligation to update forward-looking
statements contained in this estimate, except as may be required by
law.
A www.1800PublicRelations.com PR Event
Contacts: Vycor Medical, Inc Investor Contacts: Robert
B. Prag President The Del Mar Consulting Group, Inc. +1 (858)
794-9500 bprag@delmarconsulting.com or Alex Partners, LLC Scott
Wilfong President +1 (425) 242-0891 Scott@alexpartnersllc.com
Press/Media Contact: Matthew Bird President MUNCmedia Public
Relations +1 (917) 409-8211 matt.bird@muncmedia.com
www.muncmedia.com
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Jul 2023 to Jul 2024